Braidwell LP
- SEC CIK
- 0001920938
- Latest filing
- Aug 14, 2026
Holdings in Q4 2023
Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.
- Positions
- 72
- −14 vs. Q3 2023
- Portfolio value
- $2.72B
- −$441.7M (−14.0%) vs. Q3 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CMPXCompass Therapeutics, Inc. | COM | 317,761 | $495.7K | <0.1% | −5,636,512−94.7% | Reduced | History |
| Nanostring Technologies Inc63009RAD1 | NOTE 2.625% 5/0 | – | $2.72M | 0.1% | – | – | – |
| HLVXHilleVax, Inc. | COM | 203,407 | $3.26M | 0.1% | −1,245,839−86.0% | Reduced | History |
| Ionis Pharmaceuticals Inc462222AD2 | NOTE 4/0 | – | $5.54M | 0.2% | – | – | – |
| Cutera Inc232109AG3 | NOTE 4.000% 6/0 | – | $6.54M | 0.2% | – | New | – |
| ADPTAdaptive Biotechnologies Corp | COM | 1,357,490 | $6.65M | 0.2% | +389,800+40.3% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 323,102 | $7.04M | 0.3% | −1,412,080−81.4% | Reduced | History |
| DBVTDBV Technologies S.A. | SPONSORED ADR | 7,843,285 | $7.47M | 0.3% | −4,264,500−35.2% | Reduced | History |
| Cutera Inc232109AD0 | NOTE 2.250% 6/0 | – | $8.37M | 0.3% | – | – | – |
| TMDXTransMedics Group, Inc. | COM | 117,701 | $9.29M | 0.3% | −189,499−61.7% | Reduced | History |
| Neogenomics Inc64049MAA8 | NOTE 1.250% 5/0 | – | $9.38M | 0.3% | – | – | – |
| RAPTRAPT Therapeutics, Inc. | COM | 389,300 | $9.67M | 0.4% | −693,212−64.0% | Reduced | History |
| DNLIDenali Therapeutics Inc. | COM | 461,769 | $9.91M | 0.4% | +461,769 | New | History |
| LUNGPulmonx Corp | COM | 787,954 | $10.0M | 0.4% | −200,605−20.3% | Reduced | History |
| DYNDyne Therapeutics, Inc. | COM | 755,811 | $10.1M | 0.4% | −1,066,161−58.5% | Reduced | History |
| MRUSMerus N.V. | COM | 370,679 | $10.2M | 0.4% | −1,530,658−80.5% | Reduced | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 515,000 | $11.1M | 0.4% | +515,000 | New | History |
| Travere Therapeutics, Inc.89422GAA5 | NOTE 2.250% 3/0 | – | $11.1M | 0.4% | – | – | – |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 280,158 | $11.4M | 0.4% | +280,158 | New | History |
| CGEMCullinan Therapeutics, Inc. | COM | 1,240,865 | $12.6M | 0.5% | −668,000−35.0% | Reduced | History |
| OMOutset Medical, Inc. | COM | 2,400,427 | $13.0M | 0.5% | 00.0% | Unchanged | History |
| THRDThird Harmonic Bio, Inc. | COM | 1,316,018 | $14.4M | 0.5% | −337,973−20.4% | Reduced | History |
| Invitae Corp46185LAB9 | NOTE 2.000% 9/0 | – | $14.9M | 0.5% | – | – | – |
| TERNTerns Pharmaceuticals, Inc. | COM | 2,318,050 | $15.0M | 0.6% | −522,002−18.4% | Reduced | History |
| AMGNAmgen Inc | Stock | 58,200 | $16.8M | 0.6% | +22,000+60.8% | Added | History |
| HROWHarrow, Inc. | COM | 1,498,584 | $16.8M | 0.6% | −310,100−17.1% | Reduced | History |
| Ironwood Pharmaceuticals Inc46333XAH1 | NOTE 1.500% 6/1 | – | $16.9M | 0.6% | – | – | – |
| MLYSMineralys Therapeutics, Inc. | COM | 2,023,900 | $17.4M | 0.6% | 00.0% | Unchanged | History |
| RGENRepligen Corp | COM | 102,698 | $18.5M | 0.7% | −15,702−13.3% | Reduced | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 1,169,490 | $18.9M | 0.7% | −2,166,731−64.9% | Reduced | History |
| APGEApogee Therapeutics, Inc. | COM | 681,101 | $19.0M | 0.7% | +189,988+38.7% | Added | History |
| GKOSGLAUKOS Corp | COM | 242,760 | $19.3M | 0.7% | −453,032−65.1% | Reduced | History |
| GHGuardant Health, Inc. | COM | 758,928 | $20.5M | 0.8% | +69,928+10.1% | Added | History |
| TRMLTourmaline Bio, Inc. | COM | 906,820 | $23.7M | 0.9% | +906,820 | New | History |
| KRYSKrystal Biotech, Inc. | COM | 196,200 | $24.3M | 0.9% | +118,703+153.2% | Added | History |
| ALECAlector, Inc. | COM | 3,324,308 | $26.5M | 1.0% | −749,812−18.4% | Reduced | History |
| Alphatec Hldgs Inc02081GAB8 | NOTE 0.750% 8/0 | – | $28.4M | 1.0% | – | – | – |
| LNTHLantheus Holdings, Inc. | Stock | 495,100 | $30.7M | 1.1% | +206,800+71.7% | Added | History |
| Karyopharm Therapeutics Inc.48576UAA4 | NOTE 3.000%10/1 | – | $33.0M | 1.2% | – | – | – |
| MRVIMaravai Lifesciences Holdings, Inc. | COM CL A | 5,040,635 | $33.0M | 1.2% | +1,065,778+26.8% | Added | History |
| LEGNLegend Biotech Corp | SPONSORED ADS | 562,600 | $33.9M | 1.2% | −316,964−36.0% | Reduced | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 5,718,477 | $34.3M | 1.3% | +355,497+6.6% | Added | History |
| KIDSOrthopediatrics Corp | COM | 1,107,770 | $36.0M | 1.3% | +50,000+4.7% | Added | History |
| INSPInspire Medical Systems, Inc. | COM | 184,658 | $37.6M | 1.4% | +84,358+84.1% | Added | History |
| NVRONevro Corp | COM | 1,776,368 | $38.2M | 1.4% | 00.0% | Unchanged | History |
| Ironwood Pharmaceuticals Inc46333XAF5 | NOTE 0.750% 6/1 | – | $39.5M | 1.4% | – | – | – |
| ALGNAlign Technology Inc | COM | 146,313 | $40.1M | 1.5% | +21,100+16.9% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 75,749 | $40.2M | 1.5% | 00.0% | Unchanged | History |
| IMCRImmunocore Holdings plc | ADS | 611,365 | $41.8M | 1.5% | −295,608−32.6% | Reduced | History |
| FNAParagon 28, Inc. | COM | 3,361,824 | $41.8M | 1.5% | 00.0% | Unchanged | History |
| KROSKeros Therapeutics, Inc. | COM | 1,118,961 | $44.5M | 1.6% | −238,348−17.6% | Reduced | History |
| Dexcom Inc252131AK3 | NOTE 0.250%11/1 | – | $47.2M | 1.7% | – | – | – |
| Retrophin Inc761299AB2 | NOTE 2.500% 9/1 | – | $47.7M | 1.8% | – | – | – |
| Neogenomics Inc64049MAB6 | NOTE 0.250% 1/1 | – | $50.2M | 1.8% | – | – | – |
| Sarepta Therapeutics, Inc.803607AD2 | NOTE 1.250% 9/1 | – | $51.5M | 1.9% | – | – | – |
| PENPenumbra Inc | COM | 222,792 | $56.0M | 2.1% | +127,477+133.7% | Added | History |
| INSMED Inc457669AA7 | NOTE 1.750% 1/1 | – | $56.1M | 2.1% | – | – | – |
| BridgeBio Pharma, Inc.10806XAD4 | NOTE 2.250% 2/0 | – | $57.3M | 2.1% | – | – | – |
| ARGXArgenx SE | SPONSORED ADR | 153,204 | $58.3M | 2.1% | +153,204 | New | History |
| IRTCiRhythm Holdings, Inc. | COM | 568,157 | $60.8M | 2.2% | 00.0% | Unchanged | History |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 4,215,573 | $61.5M | 2.3% | +500,000+13.5% | Added | History |
| Tandem Diabetes Care Inc875372AB0 | NOTE 1.500% 5/0 | – | $67.2M | 2.5% | – | New | – |
| Insulet Corp45784PAK7 | NOTE 0.375% 9/0 | – | $72.7M | 2.7% | – | – | – |
| Nuvasive Inc670704AJ4 | NOTE 0.375% 3/1 | – | $74.3M | 2.7% | – | – | – |
| XENEXenon Pharmaceuticals Inc. | COM | 1,647,311 | $75.9M | 2.8% | −456,085−21.7% | Reduced | History |
| PCVXVaxcyte, Inc. | COM | 1,289,965 | $81.0M | 3.0% | −329,588−20.4% | Reduced | History |
| NBIXNeurocrine Biosciences Inc | Stock | 715,209 | $94.2M | 3.5% | −252,815−26.1% | Reduced | History |
| NovoCure Ltd67011XAB9 | NOTE 11/0 | – | $117.9M | 4.3% | – | – | – |
| Exact Sciences Corp30063PAC9 | NOTE 0.375% 3/0 | – | $123.1M | 4.5% | – | – | – |
| Ascendis Pharma A/S04351PAD3 | NOTE 2.250% 4/0 | – | $130.4M | 4.8% | – | – | – |
| BridgeBio Pharma, Inc.10806XAB8 | NOTE 2.500% 3/1 | – | $138.4M | 5.1% | – | – | – |
| Guardant Health, Inc.40131MAB5 | NOTE 11/1 | – | $189.1M | 6.9% | – | – | – |
Sold out since Q3 2023 (21)
Positions held at the end of Q3 2023 that are gone from this filing.
| Security | Class | Shares in Q3 2023 | Value in Q3 2023 | % of portfolio in Q3 2023 | History |
|---|---|---|---|---|---|
| Nevro Corp64157FAC7 | NOTE 2.750% 4/0 | – | $102.0M | 3.2% | – |
| BSXBoston Scientific Corp | Stock | 1,164,850 | $61.5M | 1.9% | History |
| NTRANatera, Inc. | COM | 1,012,145 | $44.8M | 1.4% | History |
| ISRGIntuitive Surgical Inc | COM NEW | 114,920 | $33.6M | 1.1% | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 1,289,872 | $25.9M | 0.8% | History |
| ETNB89bio, Inc. | COM | 1,590,387 | $24.6M | 0.8% | History |
| AXNXAxonics, Inc. | COM | 354,527 | $19.9M | 0.6% | History |
| DHRDanaher Corp | Stock | 77,200 | $19.2M | 0.6% | History |
| ANABAnaptysbio, Inc | COM | 1,049,823 | $18.9M | 0.6% | History |
| PTGXProtagonist Therapeutics, Inc | COM | 1,109,150 | $18.5M | 0.6% | History |
| INCYIncyte Corp | COM | 294,900 | $17.0M | 0.5% | History |
| Integra Lifesciences Hldgs C457985AM1 | NOTE 0.500% 8/1 | – | $13.3M | 0.4% | – |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 1,348,099 | $13.0M | 0.4% | History |
| ENTAEnanta Pharmaceuticals Inc | COM | 1,038,310 | $11.6M | 0.4% | History |
| PRCTPROCEPT BioRobotics Corp | COM | 331,061 | $10.9M | 0.3% | History |
| SKINSkinHealth Systems Inc. | COM CL A | 1,626,236 | $9.79M | 0.3% | History |
| SGENSeagen Inc. | COM | 42,497 | $9.02M | 0.3% | History |
| REPLReplimune Group, Inc. | COM | 487,520 | $8.34M | 0.3% | History |
| AGENAgenus Inc | COM NEW | 6,307,030 | $7.13M | 0.2% | History |
| RYZBRayzeBio, Inc. | COM | 277,778 | $6.17M | 0.2% | History |
| ALXOAlx Oncology Holdings Inc | COM | 1,249,900 | $6.00M | 0.2% | History |